{"id":301031,"date":"2023-09-07T18:00:27","date_gmt":"2023-09-07T12:30:27","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=301031"},"modified":"2023-09-15T13:22:33","modified_gmt":"2023-09-15T07:52:33","slug":"delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/","title":{"rendered":"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940"},"content":{"rendered":"
\n

Delhi High Court:<\/span> Two writ petitions were filed by Surgical Manufacturers and Traders Association, one challenging the Notification dated 03-12-2018 issued by the Central Government via the Ministry of Health and Family Welfare (MHFW) dealing with medical devices and the other challenging Section 3(b)(iv) and Section 5(2)<\/a> of the Drugs and Cosmetics Act, 1940<\/a>. A division bench of Rajiv Shakdher and Tara Vitasta Ganju, J., did not interfere with the notifications passed as the Association has failed to demonstrate that Sections 3(b)(iv) and 5(2) are violative of Article 14<\/a> and\/or 21<\/a> of the Constitution<\/a>. It is because there is no manifest arbitrariness or unreasonableness in the shift in policy of bringing all medical devices within the ambit of a regulatory regime.<\/p>\n

The impugned notifications brought four medical devices within the ambit of “drug” as defined under Section 3(b)(iv)<\/a> of the 1940 Act<\/a>. The 1st 2020 Notification has spread the net to cover all medical devices to the consternation of the Association. The Association claims to be a registered society representing over 400 members, spread all over India, who are in the business of manufacturing and trading in surgical, medical, hospital, and healthcare equipment and supplies both within India and those imported into the country. Thus, the grievance of the Association, in a nutshell, was that via the 1st 2020 Notification, the Central Government, instead of specifying specific devices as drugs, spread the net to include all devices that were used for one or more specific purposes indicated in the said Notification; the only exception being medical devices mentioned in Annexure to the 8th Schedule to Medical Devices Rules 2017.<\/p>\n

On the aspect of whether Section 3(b)(iv)<\/a> and Section 5(2)<\/a> of the 1940 Act<\/a> are unconstitutional since they are violative of Articles 14<\/a> and 21<\/a> of the Constitution<\/a>, the Court noted that MHFW, in its wisdom, thought it fit to bring all medical devices within the ambit of the expression “drug”. This is clearly a policy matter. If MHFW has the power to do so, no fault can be found with the 1st 2020 Notification whereby all medical devices were brought within the purview of the expression “drug”. MHFW’s reasons are manifold, which include the desire to align itself with the international regulatory regime and to further the interest of the patients. Mere errors, if any, in the policy, which is otherwise robust and devised bearing in mind patient safety, cannot be upturned by the court while exercising the power of judicial review under Article 226<\/a> of the Constitution<\/a>, unless it is a clear case of demonstrable violation of fundamental rights, including Article 14<\/a> and 21<\/a> of the Constitution<\/a>.<\/p>\n

On the submission made by the Association that the 1st 2020 Notification is a case of overbreadth, which was an aspect not envisaged under the provisions of Section 3(b)(iv)<\/a> of the 1940 Act<\/a>, the Court replied that regarding the first aspect, which concerns the inclusion of nebulisers and glucometers, one must note that these are simple home medical appliances\/devices that are freely available for introducing drugs and monitoring drug dosage. The devices, by themselves, are not complicated contraptions but certainly require standardisation. Errors made could lead to fatalities. For instance, if, in a given case, the glucometer is faulty, it could show the presence of blood sugar at a higher level than what is obtaining in a patient’s body, compelling the patient to take a higher dosage of the prescribed drug leading to rapid fall in the blood sugar level, i.e., hypoglycemia. Hypoglycemia can cause cognitive disruptions, and coma and sometimes lead to a patient’s death.<\/p>\n

The Court further noted that the DTAB is an expert statutory body constituted by the Central Government for seeking advice on technical matters. The fact that the MHFW chose to include nebulisers and glucometers in the proposals that were being considered for Notification under Section 3(b)(iv)<\/a> of the 1940 Act<\/a> would not by itself render it illegal. Thus, even though these four devices are simple home appliances, a decision was taken by the MHFW to bring them within the ambit of Section 3(b)(iv)<\/a> of the 1940 Act<\/a> as the commencement and continuation of drug therapy in a patient was acutely dependent on the correct measurements of human vitals by these devices.<\/p>\n

The Court remarked that the 2018 Notification is sustainable and cannot be found fault with only because it included two other devices, i.e., nebuliser and glucometer, which were initially not on the agenda of the 80th DTAB meeting. The fact that the Legal Metrology Act, 2009<\/a> covers certain devices such as blood pressure monitors and digital thermometers or that the glucometers are required to adhere to the standards stipulated by BIS would not render the 2018 Notification invalid. At worst, it could be a case of over-regulation, but that by itself would not result in the 2018 Notification being declared invalid in the eyes of the law.<\/p>\n

On the aspect of whether the implementation of the impugned notifications had placed an onerous burden, both in terms of finance and otherwise, on the stakeholders, the Court observed that no facts have been pleaded in the petitions to demonstrate how the alleged financial burden is onerous. Secondly, a broad perusal of the Second (2nd) Schedule appended to the 2017 Rules would show that the burden of the fee is dependent on the risk attached and whether or not the medical device is manufactured in India. Thus, insofar as Class A and B medical devices manufactured in India are concerned, which fall in the category of low risk and low-moderate risk, the fee is one-tenth for obtaining a “one site” license and half of what is stipulated for “each distinct medical device” falling under Class C and D. Compared with imported medical devices, although the fee burden is higher, the distinction between Class A and B devices [i.e., the low and low-moderate risk devices] and Class C and D devices [i.e., high-moderate and high-risk devices] is maintained.<\/p>\n

Thus, they fall into different slots, hence, the financial burden by way of fee imposed cannot be compared. This, according to us, constitutes false equivalence. The classification between medical devices manufactured locally, as against those imported, is clear and distinct and in no way a violation of Article 14<\/a> and Article 21<\/a> of the Constitution<\/a>.<\/p>\n

[The Surgical Manufactures and Traders Association v Union of India, 2023 SCC OnLine Del 5443<\/a>, decide on 01-09-2023<\/span>]<\/p>\n\n

Advocates who appeared in this case :<\/p>\n

Mr Adit S. Pujari, Mr Maitreya Subramaniam, and Ms Kajal Dalal, Advocates for petitioner<\/p>\n

Mr Kirtiman Singh, CGSC, with Ms Shreya V. Mehra and Ms Durgesh Nandini, Advocates.<\/p>\n

Buy Constitution of India  HERE<\/a><\/h3>\n

\"Constitution<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The larger public interest, which concerns patient safety, requires that all medical devices be brought within a regulatory regime. One cannot quibble with the intent, purpose and object with which the impugned notifications have been issued.<\/p>\n","protected":false},"author":67516,"featured_media":293503,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3,10],"tags":[7292,13681,2543,11151,3007,52171,60831],"class_list":["post-301031","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-casebriefs","category-highcourts","tag-article-14","tag-article-21","tag-Delhi_High_Court","tag-drugs","tag-drugs_and_cosmetics","tag-medical-devices","tag-patient-safety"],"yoast_head":"\nDelhi HC upholds decision to include all medical devices under \u2018drugs\u2019 under drug regulatory law| SCC Blog<\/title>\n<meta name=\"description\" content=\"Delhi High Court upholds Centre decision to include all medical devices under the ambit of \u2018drugs\u2019 under Drugs and Cosmetics Act, 1940.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940\" \/>\n<meta property=\"og:description\" content=\"Delhi High Court upholds Centre decision to include all medical devices under the ambit of \u2018drugs\u2019 under Drugs and Cosmetics Act, 1940.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-07T12:30:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-15T07:52:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arunima\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arunima\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/\",\"name\":\"Delhi HC upholds decision to include all medical devices under \u2018drugs\u2019 under drug regulatory law| SCC Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp\",\"datePublished\":\"2023-09-07T12:30:27+00:00\",\"dateModified\":\"2023-09-15T07:52:33+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb\"},\"description\":\"Delhi High Court upholds Centre decision to include all medical devices under the ambit of \u2018drugs\u2019 under Drugs and Cosmetics Act, 1940.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp\",\"width\":886,\"height\":590,\"caption\":\"delhi high court\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb\",\"name\":\"Arunima\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g\",\"caption\":\"Arunima\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/scc-editor_9\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Delhi HC upholds decision to include all medical devices under \u2018drugs\u2019 under drug regulatory law| SCC Blog","description":"Delhi High Court upholds Centre decision to include all medical devices under the ambit of \u2018drugs\u2019 under Drugs and Cosmetics Act, 1940.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/","og_locale":"en_US","og_type":"article","og_title":"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940","og_description":"Delhi High Court upholds Centre decision to include all medical devices under the ambit of \u2018drugs\u2019 under Drugs and Cosmetics Act, 1940.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2023-09-07T12:30:27+00:00","article_modified_time":"2023-09-15T07:52:33+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.jpg","type":"image\/jpeg"}],"author":"Arunima","twitter_card":"summary_large_image","twitter_title":"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940","twitter_misc":{"Written by":"Arunima","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/","url":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/","name":"Delhi HC upholds decision to include all medical devices under \u2018drugs\u2019 under drug regulatory law| SCC Blog","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp","datePublished":"2023-09-07T12:30:27+00:00","dateModified":"2023-09-15T07:52:33+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb"},"description":"Delhi High Court upholds Centre decision to include all medical devices under the ambit of \u2018drugs\u2019 under Drugs and Cosmetics Act, 1940.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp","width":886,"height":590,"caption":"delhi high court"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2023\/09\/07\/delhi-high-court-upholds-centre-decision-medical-devices-ambit-drugs-drug-regulatory-framework-legal-news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Delhi High Court upholds Centre decision to bring all medical devices under the ambit of \u2018drug\u2019 under Drugs and Cosmetics Act, 1940"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb","name":"Arunima","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g","caption":"Arunima"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/scc-editor_9\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":228298,"url":"https:\/\/www.scconline.com\/blog\/post\/2020\/04\/14\/medical-oxygen-ip-and-nitrous-oxide-ip-are-drugs-as-per-section-3bi-of-the-the-drugs-and-cosmetics-act-1940\/","url_meta":{"origin":301031,"position":0},"title":"Medical Oxygen IP and Nitrous Oxide IP are \u2018drugs\u2019 as per Section 3(b)(i) of the the Drugs and Cosmetics Act 1940","author":"Prachi Bhardwaj","date":"April 14, 2020","format":false,"excerpt":"Supreme Court: The bench of Dr. DY Chandrachud and Ajay Rastogi, JJ has held that Medical Oxygen IP and Nitrous Oxide IP falls within the ambit of \u2018drugs\u2019 under Section 3(b)(i) of the the Drugs and Cosmetics Act 1940 and are consequently covered in Entry 88 of the Andhra Pradesh\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2017\/09\/Supreme-Court_Colour.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2017\/09\/Supreme-Court_Colour.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2017\/09\/Supreme-Court_Colour.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2017\/09\/Supreme-Court_Colour.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2017\/09\/Supreme-Court_Colour.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":340955,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/02\/10\/cheief-secretaries-sidreted-appear-explain-non-compliance-misleading-medical-ads-sc-legal-news\/","url_meta":{"origin":301031,"position":1},"title":"SC directs Chief Secretaries of Delhi, AP and J&K to explain non-compliance of directions against misleading medical ads","author":"Sucheta","date":"February 10, 2025","format":false,"excerpt":"The Court was hearing a writ petition filed by IMA seeking regulation of medical advertisements by Patanjali Ayurved Ltd.","rel":"","context":"In "Hot Off The Press"","block_context":{"text":"Hot Off The Press","link":"https:\/\/www.scconline.com\/blog\/post\/category\/news\/hot_off_the_press\/"},"img":{"alt_text":"misleading medical ads","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/shared-image-2025-02-10T191220.431.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/shared-image-2025-02-10T191220.431.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/shared-image-2025-02-10T191220.431.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/02\/shared-image-2025-02-10T191220.431.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":292633,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/05\/19\/delhi-high-court-directs-trademark-registry-to-proceed-as-per-law-in-reviewing-use-of-hamdard-in-hamdard-roghan-badam-shirin-legal-updates\/","url_meta":{"origin":301031,"position":2},"title":"Request to review trademark \u2018HAMDARD\u2019 in \u2018HAMDARD ROGHAN BADAM SHIRIN\u2019 for its descriptive use; Delhi High Court directs Trademark Registry to proceed as per law","author":"Arunima","date":"May 19, 2023","format":false,"excerpt":"Under section 3(a) of Drugs & Cosmetics Act, 1940, Raughan-E-Badam Shireen\/ Badani Shireen is mentioned as Unani Medicine in the authoritative book of First Schedule of Drugs and Cosmetics Act, 1940.","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"delhi high court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/04\/delhi-high-court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":72142,"url":"https:\/\/www.scconline.com\/blog\/post\/2016\/09\/22\/the-drugs-and-cosmetics-sixth-amendment-rules-2016-notified\/","url_meta":{"origin":301031,"position":3},"title":"The Drugs and Cosmetics (Sixth Amendment) Rules, 2016 notified","author":"Saba","date":"September 22, 2016","format":false,"excerpt":"NOTIFICATION New Delhi, the 21st September, 2016 G.S.R. 897(E).\u2014Whereas a draft of certain rules further to amend the Drugs and Cosmetics Rules,\u00a01945, was published, as required by Section 12 read with Section 33 of the Drugs and Cosmetics Act, 1940\u00a0(23 of 1940), vide notification of the Government of India in\u2026","rel":"","context":"In "Foreign Legislation"","block_context":{"text":"Foreign Legislation","link":"https:\/\/www.scconline.com\/blog\/post\/category\/legislationupdates\/foreign\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/05\/Drugs.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/05\/Drugs.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/05\/Drugs.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/05\/Drugs.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2016\/05\/Drugs.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":252345,"url":"https:\/\/www.scconline.com\/blog\/post\/2021\/08\/06\/an-overview-of-health-tech-regulation-in-india-part-1\/","url_meta":{"origin":301031,"position":4},"title":"An Overview of Health-tech Regulation in India [Part 1]","author":"Bhumika Indulia","date":"August 6, 2021","format":false,"excerpt":"by Shantanu Mukherjee\u2020 Cite as: 2021 SCC OnLine Blog Exp 62","rel":"","context":"In "Op Eds"","block_context":{"text":"Op Eds","link":"https:\/\/www.scconline.com\/blog\/post\/category\/op-ed\/legal-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/08\/MicrosoftTeams-image-130.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/08\/MicrosoftTeams-image-130.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/08\/MicrosoftTeams-image-130.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/08\/MicrosoftTeams-image-130.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2021\/08\/MicrosoftTeams-image-130.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":275894,"url":"https:\/\/www.scconline.com\/blog\/post\/2022\/10\/18\/madras-high-court-vicarious-liability-criminal-liability-non-executive-directors-carbimazole-tablets-drugs-and-cosmetics-act-negotiable-instruments-act-legal-research-legal-news-updates\/","url_meta":{"origin":301031,"position":5},"title":"Madras High Court| Directors cannot escape criminal liability on the ground that they are not directly involved in the production of sub-standard Pharma products","author":"Editor","date":"October 18, 2022","format":false,"excerpt":"Madras High Court: In a petition filed under Section 482 of Code of Criminal Procedure (CrPC) to quash the criminal complaint filed by the Drugs Inspector under Section 32 of Drugs and Cosmetics Act, 1940, for the contravention of Section 18(a)(1) of Drugs and Cosmetics Act, 1940, (\u2018D&C Act\u2019) which\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Madras High Court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/02\/Madras-HC.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/02\/Madras-HC.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/02\/Madras-HC.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/02\/Madras-HC.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2022\/02\/Madras-HC.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/301031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67516"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=301031"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/301031\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/293503"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=301031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=301031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=301031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}